Pharma Journalist 8786 posts 0 comments

Sarepta Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices (Paragon), which will provide Sarepta access to…
Read More...

Novan announced that the Company has expanded its partnership with Sato Pharmaceutical, a Japanese company with a prescription pharmaceutical business specializing in dermatology, to…
Read More...

Amicus Therapeutics announced a major collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Hemlibra (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in…
Read More...

We are delighted to announce that Prof. Michael Alberts, Chief Medical Officer of Moffitt Cancer Center will be chairing our 7th Lung Cancer Screening & Continuum of Care …
Read More...

Boehringer Ingelheim and Eli Lilly and Company presented the full results of the long-term cardiovascular outcome trial, CARMELINA, which studied the impact of Trajenta (linagliptin) on…
Read More...

Evonik announced the launch of an advanced combination polymer for enteric coatings. EUDRAGIT® FL 30 D-55 leverages Evonik’s new, proprietary AEMP® technology (Advanced Excipient…
Read More...

Kite, a Gilead Company and HiFiBiO Therapeutics, a biotechnology company focused on the discovery of therapeutic antibodies through single B cell screening and analysis, announced the…
Read More...

Daiichi Sankyo Company announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Drug designation by the Japan Ministry of Health, Labour and Welfare (MHLW) for…
Read More...

Chugai Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by…
Read More...